Caplin Steriles receives USFDA ANDA nod for Cisatracurium Besylate Injection

Caplin Steriles receives USFDA ANDA nod for Cisatracurium Besylate Injection

by admin- Monday, June 12th, 2023 03:30:57 PM

 

Caplin Steriles, a Subsidiary organization of Caplin Point Laboratories, has been granted very last approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Cisatracurium Besylate Injection USP, 10 mg/5 mL (2 mg/mL) and 2 hundred mg/20 mL (10 mg/mL) Single-dose Vials; and 20 mg/10 mL (2 mg/mL) Multiple-dose Vials (Preserved)., a regularly occurring healing equal version of (RLD), NIMBEX injection of
AbbVie Inc.

News Updates